Cargando…
Underexpression of LKB1 tumor suppressor is associated with enhanced Wnt signaling and malignant characteristics of human intrahepatic cholangiocarcinoma
Intrahepatic cholangiocarcinoma (ICC) is a rare and highly aggressive malignancy. In this study, we identified the presence of gene deletion and missense mutation leading to inactivation or underexpression of liver kinase B1 (LKB1) tumor suppressor and excluded the involvement of LKB1 gene hypermeth...
Autores principales: | Wang, Jinghan, Zhang, Keqiang, Wang, Jinhui, Wu, Xiwei, Liu, Xiyong, Li, Bin, Zhu, Yan, Yu, Yong, Cheng, Qingbao, Hu, Zhenli, Guo, Chao, Hu, Shuya, Mu, Bing, Tsai, Chun-Hao, Li, Jie, Smith, Lynne, Yang, Lu, Liu, Qi, Chu, Peiguo, Chang, Vincent, Zhang, Baihe, Wu, Mengchao, Jiang, Xiaoqing, Yen, Yun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4662463/ https://www.ncbi.nlm.nih.gov/pubmed/26056085 |
Ejemplares similares
-
Integrin β3 and LKB1 are independently involved in the inhibition of proliferation by lovastatin in human intrahepatic cholangiocarcinoma
por: Yang, Sheng-Huei, et al.
Publicado: (2015) -
Underexpression of tumour suppressor LKB1 in clear cell renal cell carcinoma is common and confers growth advantage in vitro and in vivo
por: Duivenvoorden, W C, et al.
Publicado: (2013) -
Underexpression of Carbamoyl Phosphate Synthetase I as Independent Unfavorable Prognostic Factor in Intrahepatic Cholangiocarcinoma: A Potential Theranostic Biomarker
por: Ong, Khaa Hoo, et al.
Publicado: (2023) -
Lovastatin overcomes gefitinib resistance through TNF-α signaling in human cholangiocarcinomas with different LKB1 statuses in vitro and in vivo
por: Yang, Sheng-Huei, et al.
Publicado: (2015) -
Underexpression of miR-126-3p in Patients with Cholangiocarcinoma
por: Spinola, Lucas P, et al.
Publicado: (2021)